FBR Analyst Comments on Skirmish Between Express Scripts (ESRX) and Horizon Pharma (HZNP)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - Mizuho
November 11, 2015 11:57 AM ESTMizuho Securities analyst Irina Koffler reiterated a Buy rating and $34 price target on Horizon Pharma (NASDAQ: HZNP), saying they expect minimal impact from Linden disruption.
Koffler commented, "We spoke with management and learned that Linden processes ~150-200 prescriptions for Duexis, Vimovo, Pennsaid, and... More
DepoMed (DEPO) Sell-Off on Horizon News a 'Buying Opportunity'- Janney
November 11, 2015 11:48 AM ESTJanney Capital analyst Ken Trbovich reiterated a Buy rating and $35 fair value target on DepoMed Inc (NASDAQ: DEPO) calling today's sell-off on bad Horizon Pharma (NASDAQ: HZNP) a "buying opportunity."
Trbovich commented, "Today's sell off is completely... More
Insys Therapeutics (INSY) Trades Lower in Sympathy with Horizon Pharma (HZNP)
November 11, 2015 9:25 AM ESTInsys Therapeutics (NASDAQ: INSY) shares traded lower in sympathy with Horizon... More
Horizon Pharma (HZNP) Responds to Express Scripts' (ESRX) Lawsuit; Says Linden Care Isn't So-Called 'Captive Pharmacy'
November 11, 2015 6:42 AM ESTHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts (NASDAQ: ESRX) and recent allegations:
Our primary concern is for the patients who, based on the profit driven actions of Express Scripts, may be denied access to medicines that are prescribed by their physicians. We are committed to ensuring that regardless of these actions,... More
